Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CYSLTR1 antagonism displays potent anti-tumor effects in uveal melanoma. | Exp Eye Res | 2024 | 39389443 | PubTator, text mining | PubMed |
| CSER: a gene regulatory network construction method based on causal strength and ensemble regression. | Front Genet | 2024 | 39371416 | PubTator, text mining | PubMed |
| [Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches]. | Mol Biol (Mosk) | 2024 | 39355878 | PubTator, text mining | PubMed |
| Mosaic GNAQ and GNA11 mutations may cause phacomatosis melanorosea and phacomatosis melanocesioflammea. | Pediatr Investig | 2024 | 39347525 | PubTator, text mining | PubMed |
| Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. | Int J Clin Oncol | 2024 | 39249554 | PubTator, text mining | PubMed |
| [Familial Hypocalciuric Hypercalcemia Type 1 Likely Secondary to a New Inactivating Mutation of CASR]. | G Ital Nefrol | 2024 | 39243411 | PubTator, text mining | PubMed |
| NRASQ61R-driven atypical melanocytic tumor with blue nevus-like morphology: A case report. | J Cutan Pathol | 2024 | 39177027 | PubTator, text mining | PubMed |
| Familial hypocalciuric hypercalcemia in an infant: diagnosis and management quandaries. | J Bone Miner Res | 2024 | 39163488 | PubTator, text mining | PubMed |
| Segmental congenital vascular anomaly with atrophy, ulceration, and scarring (SeCVAUS): Case series and review of literature. | Pediatr Dermatol | 2024 | 39161100 | PubTator, text mining | PubMed |
| Impact of Driver Mutations on Metastasis-Free Survival in Uveal Melanoma: A Meta-Analysis. | Cancers (Basel) | 2024 | 39061150 | PubTator, text mining | PubMed |
| Primary Meningeal Melanocytic Tumors of the Central Nervous System: A Review from the Ultra-Rare Brain Tumors Task Force of the European Network for Rare Cancers (EURACAN). | Cancers (Basel) | 2024 | 39061148 | PubTator, text mining | PubMed |
| Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status. | Invest Ophthalmol Vis Sci | 2024 | 39042403 | PubTator, text mining | PubMed |
| RhoA-mediated G12-G13 signaling maintains muscle stem cell quiescence and prevents stem cell loss. | Cell Discov | 2024 | 39009565 | PubTator, text mining | PubMed |
| Delineation of the phenotypes and genotypes of PIK3CA-related overgrowth spectrum in East asians. | Mol Genet Genomics | 2024 | 38980418 | PubTator, text mining | PubMed |
| Somatic GNA11/GNAQ variants in a cohort of Chinese children with phakomatosis pigmentovascularis. | Pediatr Investig | 2024 | 38910853 | PubTator, text mining | PubMed |
| Identification of Vascular Genes Differentially Expressed in the Brain of Patients with Alzheimer's Disease. | Curr Vasc Pharmacol | 2024 | 38910465 | PubTator, text mining | PubMed |
| Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma. | Front Immunol | 2024 | 38903495 | PubTator, text mining | PubMed |
| Critical role of Gα12 and Gα13 proteins in TGF-β-induced myofibroblast differentiation. | bioRxiv | 2024 | 38854083 | PubTator, text mining | PubMed |
| Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. | Oncologist | 2024 | 38761384 | PubTator, text mining | PubMed |
| Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case report. | J Cutan Pathol | 2024 | 38757469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=8